Literature DB >> 11196714

Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient mice.

L Stevceva1, P Pavli, A Husband, K I Matthaei, I G Young, W F Doe.   

Abstract

Tissue eosinophilia is a feature of idiopathic inflammatory bowel disease and other forms of colonic inflammation but it is not clear whether the role of eosinophils in the disease process is to contribute to tissue damage. Interleukin 5 (IL-5) stimulates production and activation of eosinophils in vitro and enhances immunoglobulin A (IgA) production. As very little is known about the function of IL-5 in the colon, the aim of this study was to assess its role in colonic inflammation. IL-5 deficient mice were studied using the dextran sulphate sodium (DSS)-induced colitis model and the results compared to a congenic IL-5+/+ strain. The absence of IL-5 resulted in reduction of tissue eosinophilia (P < 0.0001) but was not reflected in differences in the severity of the disease (P > 0.5) or in the extent of tissue damage in this model of colitis. Numbers of immunoglobulin-containing cells in IL-5 deficient mice were similar to those in the IL-5+ mice. We conclude that the main role of IL-5 in DSS-induced colonic inflammation is to attract a population of eosinophils which do not appear to contribute significantly to the initiation or development of tissue damage in this model of colitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11196714     DOI: 10.1038/sj.gene.6363654

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  15 in total

1.  Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils.

Authors:  Arthur Wang; Maria Fernando; Gabriella Leung; Van Phan; David Smyth; Derek M McKay
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

2.  Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility.

Authors:  Simon P Hogan; Luqman Seidu; Carine Blanchard; Katherine Groschwitz; Anil Mishra; Margaret L Karow; Richard Ahrens; David Artis; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2006-07       Impact factor: 10.793

3.  Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells.

Authors:  Eric J Albert; Jon Duplisea; Wojciech Dawicki; Ian D Haidl; Jean S Marshall
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

4.  Antibody to eosinophil cationic protein suppresses dextran sulfate sodium-induced colitis in rats.

Authors:  Kazuko Shichijo; Kazuya Makiyama; Chun-Yang Wen; Mutsumi Matsuu; Toshiyuki Nakayama; Masahiro Nakashima; Makoto Ihara; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

5.  CD34 is required for infiltration of eosinophils into the colon and pathology associated with DSS-induced ulcerative colitis.

Authors:  Steven Maltby; Carolin Wohlfarth; Matthew Gold; Lori Zbytnuik; Michael R Hughes; Kelly M McNagny
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

Review 6.  Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections.

Authors:  Pooja Mehta; Glenn T Furuta
Journal:  Immunol Allergy Clin North Am       Date:  2015-06-17       Impact factor: 3.479

7.  Eosinophils infiltrate thyroids, but have no apparent role in induction or resolution of experimental autoimmune thyroiditis in interferon-gamma(-/-) mice.

Authors:  Yujiang Fang; Kemin Chen; Daniel A Jackson; Gordon C Sharp; Helen Braley-Mullen
Journal:  Immunology       Date:  2009-10-21       Impact factor: 7.397

8.  Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis.

Authors:  Angélica T Vieira; Caio T Fagundes; Ana Leticia Alessandri; Marina G M Castor; Rodrigo Guabiraba; Valdinéria O Borges; Kátia Daniella Silveira; Erica L M Vieira; Juliana L Gonçalves; Tarcilia A Silva; Maud Deruaz; Amanda E I Proudfoot; Lirlândia P Sousa; Mauro M Teixeira
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

9.  Effects of proteoglycan on dextran sulfate sodium-induced experimental colitis in rats.

Authors:  Sakae Ota; Shuichi Yoshihara; Keinosuke Ishido; Masanori Tanaka; Keiichi Takagaki; Mutsuo Sasaki
Journal:  Dig Dis Sci       Date:  2008-05-08       Impact factor: 3.199

10.  The inflammatory infiltrate in the acute stage of the dextran sulphate sodium induced colitis: B cell response differs depending on the percentage of DSS used to induce it.

Authors:  Liljana Stevceva; Paul Pavli; Alan J Husband; William F Doe
Journal:  BMC Clin Pathol       Date:  2001
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.